#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Spinal muscular atrophy Spinal cord injury Chemical burn Hypotransferrinaemia Metachromatic leukodystrophy Acquired ATTR amyloidosis Hepatic angiosarcoma Optic glioma Myelofibrosis Chorioretinitis Infective uveitis Bronchiolitis Albright's disease Cervix carcinoma recurrent Osteosarcoma recurrent More trials…

    Learn about Rare Diseases

    Hereditary optic atrophy – Basic Information Progressive supranuclear palsy – Life with Disease Ocular melanoma – Life with Disease Retinitis pigmentosa – Life with Disease Skin angiosarcoma – Diagnostics Alexander disease – Treatment Advanced systemic mastocytosis – Diagnostics Osteosarcoma recurrent – Diagnostics Progressive multifocal leukoencephalopathy – Life with Disease Congenital hypotransferrinaemia – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    RNMB1 Capsaicin Levamlodipine Succinate Human Mesenchymal Stem Cells Binimetinib Sodium Chloride Tasquinimod Sunitinib Immunoglobulin G Rocatinlimab Sodium Phenylbutyrate Fidanacogene Elaparvovec Tropicamide Aztreonam VRDN-003 2-DEOXY-D-GLUCOSE Rosuvastatin Pseudoephedrine Hydrochloride Natalizumab Taldefgrobep Alfa More therapies…

    Learn about Your Condition

    Progressive supranuclear palsy Dystonia Lung adenocarcinoma Vascular malformation Pituitary tumour benign Mesothelioma malignant Lymphoma Henoch-Schonlein purpura Oropharyngeal cancer recurrent Endometrial cancer metastatic Cleft lip and palate Mantle cell lymphoma Acute myeloid leukaemia Genital herpes simplex Breast cancer male More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Theophylline, Gadoteric Acid, and Regadenoson for Patients with Chronic Total Coronary Artery Blockage

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic disease
    • Coronary artery occlusion
    Investigated Drugs:
    • THEOPHYLLINE ANHYDROUS
    • Regadenoson
    • Gadoteric Acid
    Spain

  • Study on the Safety of Micronized Progesterone and Norethisterone Acetate with Estradiol for Menopausal Symptoms in Women

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Menopausal symptoms
    Investigated Drugs:
    • Estradiol
    • Progesterone, Micronised
    • NORETHISTERONE ACETATE
    Sweden

  • A study comparing epinephrine and isoprenaline in patients with out-of-hospital cardiac arrest who have non-shockable heart rhythm

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiac arrest
    Investigated Drugs:
    • Isoprenaline Hydrochloride
    • Epinephrine
    Denmark

  • Study on Sedation Safety and Effectiveness in Bronchoscopy: Comparing Propofol/Pethidine and Midazolam/Pethidine for Patients with Respiratory Conditions

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Dobutamine Hydrochloride
    • PETHIDINE HYDROCHLORIDE
    • Propofol
    Italy

  • Study on the Effects of Dapagliflozin for Patients with Heart Failure with Preserved Ejection Fraction

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Heart failure with preserved ejection fraction
    Investigated Drugs:
    • Dapagliflozin
    Spain

  • Study on the Effects of Inhaled Nitric Oxide on Heart and Lung Function After Cardiac Surgery

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Nitric Oxide
    Spain
Previous Page
1 … 802 803 804 805 806 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!